2-(3-(Cyclobutylmethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Catalog No.: 
ACPFWU950
CAS No.: 
2246562-24-1
Molecular Formula: 
C17H25BO3
Molecular Weight: 
288.20
2-(3-(Cyclobutylmethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-(Cyclobutylmethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
IUPAC Name2-(3-(cyclobutylmethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
MDL No.MFCD31916118
Molecular FormulaC17H25BO3
Molecular Weight288.20
SMILESCC1(C)C(C)(C)OB(C2=CC=CC(OCC3CCC3)=C2)O1
InChI KeyOYTLBJSVRTXHDR-UHFFFAOYSA-N
Synonym2-(3-(Cyclobutylmethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;1,3,2-Dioxaborolane, 2-[3-(cyclobutylmethoxy)phenyl]-4,4,5,5-tetramethyl-
CAS No.2246562-24-1

Synthetic Route by SureRoute

1. ACPFWU950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBQUE625 route compound structure diagram
    ACBQUE625214360-76-6In Stock
  4. Then
  5. ACPFWU950 route product structure diagram
    ACPFWU9502246562-24-1
Inquiry

2. ACPFWU950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  4. Then
  5. ACPFWU950 route product structure diagram
    ACPFWU9502246562-24-1
Inquiry

3. ACPFWU950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBQUE625 route compound structure diagram
    ACBQUE625214360-76-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPFWU950 route product structure diagram
    ACPFWU9502246562-24-1
Inquiry

Comments (0)